BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 8.94
-0.36 (-3.87%)
Nov 4, 2026, 4:50 PM CET
BioMaxima Market Cap
BioMaxima has a market cap or net worth of 37.49 million as of November 4, 2026. It is the 41,434th most valuable company in the world and the 379th biggest in Poland. Its market cap has decreased by 32.53% in one year.
Market Cap
37.49M
Enterprise Value
52.96M
Revenue
60.64M
Global Rank
Country Rank
#379 Poland
PE Ratio
46.34
ChartMarket Cap Chart
Since July 21, 2010, BioMaxima's market cap has increased from 11.40M to 37.49M, an increase of 228.72%. That is a compound annual growth rate of 7.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 37.49M | -25.81% |
| Dec 30, 2025 | 50.53M | 12.62% |
| Dec 30, 2024 | 44.87M | -34.84% |
| Dec 29, 2023 | 68.85M | -35.28% |
| Dec 30, 2022 | 106.38M | -6.37% |
| Dec 30, 2021 | 113.62M | -4.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 4.98B |
| NEUCA | 3.10B |
| Synektik Spólka Akcyjna | 2.75B |
| Voxel | 1.59B |
| Genomed Spólka Akcyjna | 49.95M |
| Biogened | 46.67M |
| Genomtec | 43.43M |
| MedApp | 40.27M |